OncoZenge AB
| Position | Amount | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 2021-03-08 | OncoZenge AB | Anna Helena Constance Ljung | Chairman of the Board of Directors | Subscription | 9 757 | 10,25 | SEK | 100 009,25 | 2021-03-07 |
| 2021-03-08 | OncoZenge AB | Cindy Wong | Other member of the company's administrative, management or supervisory body | Subscription | 20 000 | 10,25 | SEK | 205 000 | 2021-03-04 |
| 2021-03-08 | OncoZenge AB | Pirkko Vilja Päivikki Sulila Tamsen | Chief Executive Officer (CEO)/Managing Directory | Subscription | 20 000 | 10,25 | SEK | 205 000 | 2021-03-04 |
| 2021-03-08 | OncoZenge AB | Pirkko Vilja Päivikki Sulila Tamsen | Chief Executive Officer (CEO)/Managing Directory | Acquisition | 13 900 | 11,11 | SEK | 154 429 | 2021-03-04 |
| 2021-03-08 | OncoZenge AB | Pirkko Vilja Päivikki Sulila Tamsen | Chief Executive Officer (CEO)/Managing Directory | Disposal | 134 086 | 1,15 | SEK | 154 198,9 | 2021-03-01 |
| 2021-03-08 | OncoZenge AB | Pirkko Vilja Päivikki Sulila Tamsen | Chief Executive Officer (CEO)/Managing Directory | Disposal | 41 135 | 0 | SEK | 0 | 2021-02-18 |
| 2021-03-08 | OncoZenge AB | Hilde Furberg | Member of the Board of Directors | Acquisition | 14 635 | 0 | SEK | 0 | 2021-02-18 |
| 2021-03-08 | OncoZenge AB | Hilde Furberg | Member of the Board of Directors | Subscription | 14 635 | 10,25 | SEK | 150 008,75 | 2021-03-04 |
| 2021-03-09 | OncoZenge AB | Pirkko Vilja Päivikki Sulila Tamsen | Chief Executive Officer (CEO)/Managing Directory | Exercise decrease | 335 | 0 | SEK | 0 | 2021-03-04 |
| 2021-03-09 | OncoZenge AB | Torben Mogensen | Member of the Board of Directors | Subscription | 10 633 | 10,25 | SEK | 108 988,25 | 2021-03-07 |
| 2021-03-10 | OncoZenge AB | Mattias Klintemar | Member of the Board of Directors | Exercise decrease | 1 | 0 | SEK | 0 | 2021-03-07 |
| 2023-09-21 | OncoZenge AB | Stian Kildal | Chief Executive Officer (CEO)/Managing Directory | Acquisition | 40 000 | 3,1 | SEK | 124 000 | 2023-09-20 |
| 2023-09-21 | OncoZenge AB | Stian Kildal | Chief Executive Officer (CEO)/Managing Directory | Acquisition | 60 000 | 2,91 | SEK | 174 600 | 2023-09-19 |
| 2023-11-01 | OncoZenge AB | Stian Kildal | Chief Executive Officer (CEO)/Managing Directory | Acquisition | 500 000 | 0,368 | SEK | 184 000 | 2023-10-31 |
| 2023-11-01 | OncoZenge AB | Niclas Holmgren | Member of the Board of Directors | Acquisition | 350 000 | 0,368 | SEK | 128 800 | 2023-10-31 |
| 2023-11-02 | OncoZenge AB | Christoph Nowak | Member of the Board of Directors | Acquisition | 350 000 | 0,368 | SEK | 128 800 | 2023-11-01 |
| 2023-11-02 | OncoZenge AB | Per Daniel Ehrenstråhle | Chairman of the Board of Directors | Acquisition | 350 000 | 0,368 | SEK | 128 800 | 2023-10-31 |
| 2023-11-15 | OncoZenge AB | Stian Kildal | Chief Executive Officer (CEO)/Managing Directory | Acquisition | 25 000 | 2,786 | SEK | 69 650 | 2023-11-14 |
| 2024-01-10 | OncoZenge AB | Stian Kildal | Chief Executive Officer (CEO)/Managing Directory | Acquisition | 25 000 | 3,16 | SEK | 79 000 | 2024-01-08 |
| 2024-05-06 | OncoZenge AB | Niclas Holmgren | Member of the Board of Directors | Inheritance received | 100 000 | 3,945 | SEK | 394 500 | 2024-05-05 |